2009/3/EC: Commission Decision of 18 December 2008 establishing Community reserves of vaccines against African horse sickness

1 For emergency use the Community shall make arrangements for the purchase of 100000 doses of lyophilised monovalent attenuated live vaccines, including the necessary diluents, against African horse sickness of each of the serotypes 1, 2, 3, 4, 6, 7 and 8.

2 The arrangements referred to in paragraph 1 shall include the supply and storage of the total of 700000 doses of lyophilised vaccines and the shipment without delay of the specified vaccines to a place in the European Union, or its epidemiologically relevant direct neighbourhood, designated in case of emergency by the Commission.

The maximum cost of the measures referred to in Article 1 shall be up to EUR 500000 for a period of two years.

To meet the objectives of Articles 1 and 2 the Commission shall conclude for the years 2009 and 2010 a supply contract with Onderstepoort Biological Products Ltd (OBP) in South Africa on: the supply and storage of the vaccines described in Article 1(1), the delivery of the vaccines together with the diluents as described in Article 1(2), and the details of disposal of expired vaccines.